Company / PP&E (Net)
Doximity PP&E (Net) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$13.7M
FY2025
5-year range
$7.6M / $13.7M
FY2021-FY2025
Trend
+10.9%
vs FY2024
Sector context
#120 of 135
Health Care
What the data says
Doximity's pp&e (net) of $14M is lower than 89% of companies in the Health Care sector (FY2025). PP&E (Net) has increased for 4 consecutive years, from $8M in FY2021 to $14M in FY2025.
Based on SEC 10-K filings.
$14M in FY2025 with a 3-year CAGR of +17.2%.
Improved from $11M to $14M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +17.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 135This company $13.7M Sector average $1.4B
▼
-99.0% below sector average
Key checks
Key Insights
- Doximity's pp&e (net) has grown for 4 consecutive years.
- 3-year CAGR of +17.2%, indicating consistent growth.
- In FY2025, pp&e (net) increased 10.9% year-over-year.
- Ranks #120 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.7M | +10.9% |
| FY2024 | $12.3M | +9.2% |
| FY2023 | $11.3M | +32.9% |
| FY2022 | $8.5M | +11.7% |
| FY2021 | $7.6M | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026